drugset / Trial / NCT00893880

A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis

NCT00893880

Phase 2 Completed 92 enrolled Nitric BioTherapeutics, Inc
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A multi-arm trial to evaluate the efficacy and safety of using gaseous nitric oxide to treat moderate to severe tinea pedis.

Timeline

Start
2009-06
Primary completion
2010-01
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 1 %

Indications